CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 128 filers reported holding CRINETICS PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,366,665 | +35.1% | 121,153 | +115.8% | 0.04% | +9.4% |
Q2 2023 | $1,011,877 | +88.5% | 56,153 | +68.0% | 0.03% | +100.0% |
Q1 2023 | $536,741 | -100.0% | 33,421 | -63.1% | 0.02% | -52.9% |
Q3 2022 | $1,777,000,000 | +9.0% | 90,460 | +3.4% | 0.03% | +41.7% |
Q2 2022 | $1,631,000,000 | – | 87,460 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Saturn V Capital Management LP | 623,819 | $11,336,501 | 9.41% |
Finepoint Capital LP | 822,745 | $15,056 | 4.87% |
Bain Capital Life Sciences Investors, LLC | 2,305,558 | $42,192 | 4.72% |
Opaleye Management Inc. | 732,000 | $13,395,600 | 4.66% |
5AM Venture Management, LLC | 862,286 | $15,779,834 | 4.24% |
SPHERA FUNDS MANAGEMENT LTD. | 671,644 | $12,291,085 | 2.64% |
First Light Asset Management, LLC | 1,329,313 | $24,326,428 | 2.26% |
BRAIDWELL LP | 3,469,674 | $63,495,034 | 2.13% |
BVF INC/IL | 2,736,613 | $50,080,018 | 2.11% |
Perceptive Advisors | 4,039,276 | $73,918,751 | 2.08% |